NASDAQ : MBAI
Check-Cap Ltd. — Key statistics
Healthcare · Diagnostics & Research · Israel
Last price 2.09 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 31.96M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 28.45M |
| Enterprise Value | 28.06M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 15.29M |
| Shares Outstanding | 15.29M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 50.18% |
| Owned by Institutions (%) | 0.13% |
| Float | 7.62M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 78.66 |
| Forward PE | n/a |
| PS Ratio | 12.31 |
| Forward PS | n/a |
| PB Ratio | 15.91 |
| P/TBV Ratio | 11.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 55.86 |
| EV / Sales | 12.15 |
| EV / EBITDA | 50.00 |
| EV / EBIT | 56.93 |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.01 |
| Quick Ratio | 1.99 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 0.73 |
| Debt / FCF | n/a |
| Interest Coverage | 40.24 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 39.22% |
| Return on Assets (ROA) | 17.15% |
| Return on Invested Capital (ROIC) | 39.99% |
| Return on Capital Employed (ROCE) | 18.93% |
| Weighted Average Cost of Capital (WACC) | 8.58% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.29 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 43,626 |
| Effective Tax Rate | 7.91% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.80 |
| 52-Week Price Change | -80.68% |
| 50-Day Moving Average | 4.50 |
| 200-Day Moving Average | 9.12 |
| Relative Strength Index (RSI) | 25.59 |
| Average Volume (20 Days) | 18,276 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 16,151 |
| Short Previous Month | 19,472 |
| Short % of Shares Out | 0.11% |
| Short % of Float | 0.21% |
| Short Ratio (days to cover) | 0.84 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 2.33M |
| Gross Profit | 1.29M |
| Operating Income | 498,300 |
| Pretax Income | 551,477 |
| Net Income | 507,851 |
| EBITDA | 567,397 |
| EBIT | 498,300 |
| Earnings Per Share (EPS) | $0.02 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 799,468 |
| Total Debt | 416,000 |
| Net Cash | 383,468 |
| Net Cash Per Share | $0.03 |
| Equity (Book Value) | 2.59M |
| Book Value Per Share | 0.12 |
| Working Capital | 825,692 |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -592,997 |
| Capital Expenditures | -615,082 |
| Depreciation & Amortization | 69,097 |
| Net Borrowing | -167,202 |
| Free Cash Flow | -1.21M |
| FCF Per Share | -$0.08 |
Margins
| Measure | Value |
|---|
| Gross Margin | 55.20% |
| Operating Margin | 21.34% |
| Pretax Margin | 23.62% |
| Profit Margin | 21.75% |
| EBITDA Margin | 24.30% |
| EBIT Margin | 21.34% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 1.27% |
| FCF Yield | -4.20% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 127.19% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Aug 13, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:7 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.65 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |